Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Edstein

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|May 23, 2007
Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjectsBruce G Charles, Ann K Miller, Peter E Nasveld, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2021
Multidrug-Resistant Plasmodium falciparum Parasites in the Central Highlands of Vietnam Jeopardize Malaria Control and Elimination StrategiesHuynh Hong Quang, Marina Chavchich, Nguyen Thi Minh Trinh, et al.
Molecules (Basel, Switzerland)|December 11, 2022
Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic StudyGeoffrey W Birrell, Karin Van Breda, Bridget Barber, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2009
Evaluation of artemisone combinations in Aotus monkeys infected with Plasmodium falciparumNicanor Obaldia, Barbara M Kotecka, Michael D Edstein, et al.
The Journal of Pharmacy and Pharmacology|October 13, 2012
Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malariaKerenaftali Klein, Leon Aarons, Feiko O Ter Kuile, et al.
British Journal of Clinical Pharmacology|May 26, 2006
Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects?Bui Tri Cuong, Vu Quoc Binh, Bui Dai, et al.
Plos One|October 20, 2021
Cross-sectional survey of asymptomatic malaria in Dak Nong province in the Central Highlands of Vietnam for the malaria elimination roadmapHuynh Hong Quang, Marina Chavchich, Nguyen Thi Minh Trinh, et al.
Journal of Medicinal Chemistry|August 17, 2017
Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine-Guanine-(Xanthine) PhosphoribosyltransferasePetr Špaček, Dianne T Keough, Marina Chavchich, et al.
International Journal for Parasitology|May 31, 2016
Persistence and immunogenicity of chemically attenuated blood stage Plasmodium falciparum in Aotus monkeysSai Lata De, Danielle I Stanisic, Karin van Breda, et al.
Journal of Medicinal Chemistry|December 16, 2014
Aza-acyclic nucleoside phosphonates containing a second phosphonate group as inhibitors of the human, Plasmodium falciparum and vivax 6-oxopurine phosphoribosyltransferases and their prodrugs as antimalarial agentsDianne T Keough, Dana Hocková, Zlatko Janeba, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|May 23, 2007
Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjectsBruce G Charles, Ann K Miller, Peter E Nasveld, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2021
Multidrug-Resistant Plasmodium falciparum Parasites in the Central Highlands of Vietnam Jeopardize Malaria Control and Elimination StrategiesHuynh Hong Quang, Marina Chavchich, Nguyen Thi Minh Trinh, et al.
Molecules (Basel, Switzerland)|December 11, 2022
Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic StudyGeoffrey W Birrell, Karin Van Breda, Bridget Barber, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2009
Evaluation of artemisone combinations in Aotus monkeys infected with Plasmodium falciparumNicanor Obaldia, Barbara M Kotecka, Michael D Edstein, et al.
The Journal of Pharmacy and Pharmacology|October 13, 2012
Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malariaKerenaftali Klein, Leon Aarons, Feiko O Ter Kuile, et al.
British Journal of Clinical Pharmacology|May 26, 2006
Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects?Bui Tri Cuong, Vu Quoc Binh, Bui Dai, et al.
Plos One|October 20, 2021
Cross-sectional survey of asymptomatic malaria in Dak Nong province in the Central Highlands of Vietnam for the malaria elimination roadmapHuynh Hong Quang, Marina Chavchich, Nguyen Thi Minh Trinh, et al.
Journal of Medicinal Chemistry|August 17, 2017
Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine-Guanine-(Xanthine) PhosphoribosyltransferasePetr Špaček, Dianne T Keough, Marina Chavchich, et al.
International Journal for Parasitology|May 31, 2016
Persistence and immunogenicity of chemically attenuated blood stage Plasmodium falciparum in Aotus monkeysSai Lata De, Danielle I Stanisic, Karin van Breda, et al.
Journal of Medicinal Chemistry|December 16, 2014
Aza-acyclic nucleoside phosphonates containing a second phosphonate group as inhibitors of the human, Plasmodium falciparum and vivax 6-oxopurine phosphoribosyltransferases and their prodrugs as antimalarial agentsDianne T Keough, Dana Hocková, Zlatko Janeba, et al.
Pageof 9